200 likes | 300 Vues
MicroTransponder Inc. specializes in advanced neurostimulation technology aimed at treating neurological conditions, including chronic pain. With their 16-channel rechargeable implantable pulse generator, they provide a solution for over 30,000 patients, addressing challenges like lead migration and battery toxicity. Their systems leverage artificial intelligence and explore neuroplasticity, aiming to enhance treatment outcomes for conditions such as tinnitus and epilepsy. These advancements showcase the potential of combining medical devices with cutting-edge technology in improving patient care.
E N D
MicroTransponder, Inc. Confidential, by Will Rosellini, JD, MBA, MS President and CEO 2/8/2008 Confidential
Our Cyborg Vice President Confidential
Currently available… 30,000 people Confidential
Currently available… 16 channel rechargeable implantable pulse generator for treatment of chronic pain ANS – Plano, Texas Confidential
Currently available… Cyberonics - Houston, Texas Vagus Nerve Stimulation Epilepsy, Depression 32,000 patients Confidential
Disadvantages… Wires and Leads • Body movement can cause lead migration and reoperation • Lead fractures requires additional surgery • Infection issues Battery • Toxic to body • Can fail and require surgery to replace • Must be recharged frequently • Visible lump in skin Inside the body Outside the body BATTERY WIRES / LEADS CONTROL DEVICE Confidential
Cochlear Implant Confidential
Neuroplasticity High Pitch Low Cochlea Cortex Confidential
Problem: Solution: Auditory cortex Map Plasticity Decreased attention span due to attention to ringing ACh Nucleus Basalis Tinnitus = Synchronous Spontaneous Activity Stress/Anxiety LC Auditory Cortex Map Reorganization Cochlea NTS Hearing Loss or Noise Exposure • + • Vagal Nerve Stimulation Confidential
Abnormal Map High +VNS Low +VNS Cochlea Cortex Confidential
Restored Map High Low Cochlea Cortex Confidential
Normal Topography in somatosensory cortex • Index • Middle • Ring • Little Thumb Confidential
Amputation-Induced Cortical Plasticity Confidential
MicroTransponder Summary MicroTransponder Inc. is a medical device company with intellectual property that enables a unique neurostimulation system for the treatment of neurological disease Confidential
Artificial Intelligence Program trading AI • In 2006 at the London Stock Exchange, over 40% of all orders were entered by algo traders, with 60% predicted for 2007 • Half of all financial transactions in the world and 80% in the USA. • $30 billion per year in R&D Confidential
Google Ambitions • Google sees search as essentially a basic form of artificial intelligence. • A year ago, Google executives said the company had achieved just 5% of its complete vision of search. • Google's search engine will eventually have to know what people are thinking, how to interpret language, even the way users' brains operate. Confidential
Simulating the Brain Blue Brain • Currently they have simulated one column of a neocortex (of a rat) with 10,000 neurons and 30 million synapses using a 22.8 teraflop supercomputer. • (A human neocortex column has 60,000 neurons) Confidential
Quantum Computing Dwave • DWAVE adiabatic quantum computers could reach 512 to 1000 qubits and performance superior to classical computers in 2008 • Successful development of quantum computers would accelerate the development of molecular nanotechnology with superior molecular simulation and modeling. Confidential
Smartphones Next 10 years…. • Teraflop+ class smartphones that are constantly charged with gigabit+ connections seems likely. • Network to quantum computers and supercomputers of all types for remote processing. • Nvidia Tesla multi-teraflop GPGPU's and AMDs GPGPU Confidential